All in the family: back-to-back kinase inhibitors for the treatment of chronic lymphocytic Leukemia

Haematologica. 2021 Sep 1;106(9):2300-2301. doi: 10.3324/haematol.2021.278535.
No abstract available

Publication types

  • Editorial
  • Research Support, Non-U.S. Gov't
  • Comment

MeSH terms

  • Agammaglobulinaemia Tyrosine Kinase
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell* / drug therapy
  • Protein Kinase Inhibitors / therapeutic use

Substances

  • Protein Kinase Inhibitors
  • Agammaglobulinaemia Tyrosine Kinase